The disassembly of the clathrin lattice surrounding coated vesicles is the obligatory last step in their life cycle. It is mediated by the coordinated recruitment of auxilin and Hsc70, an ATP-driven molecular clamp. Here, we describe the preparation of reagents and the single-particle fluorescence microscopy imaging assay in which we visualize directly the Hsc70-driven uncoating of synthetic clathrin coats or clathrincoated vesicles.
Introduction
The disassembly of the clathrin coat occurs shortly after the scission of the coated vesicle from the donor membrane and represents a key step in the life cycle of a clathrin-coated vesicle (CCV) [1] [2] [3] [4] . The uncoating reaction depends on ATP hydrolysis [5] [6] [7] , and is jointly mediated by interactions by the molecular chaperone heat shock cognate protein 70 (Hsc70) that binds to the unstructured C-terminal tail of clathrin heavy chain with its cochaperone auxilin [8] also recruited to the coated vesicle [3, 5, 9] . Ensemble in vitro measurements of the uncoating reaction of natural coated vesicles or clathrin coats (CCs) assembled from purified clathrin and adaptor proteins (AP-2) have resolved key molecular steps of the process [5, 7] . We recently developed a fluorescence microscopy method to observe the uncoating reaction at the level of individual synthetic clathrin coats reconstituted with the AP-2 adaptor complex [8] . Here, we describe in detail use of this method to Till Böcking and Srigokul Upadhyayula contributed equally to the chapter.
follow the uncoating mediated by recombinant Hsc70 and auxilin of fluorescently tagged CCs or of in vitro reconstituted CCVs. Fluorescent clathrin trimers reconstituted from recombinant heavy chain and light chain labeled with a fluorophore were either mixed with the adaptor protein complex AP-2 for assembly into CCs (Fig. 1a) or mixed with AP-2 and extruded liposomes with tyrosine-motif (YQRL) containing peptidolipid for assembly into CCVs (Fig. 1b) . The clathrin-coated structures were immobilized at the bottom of a microfluidic channel device on a passivated glass coverslip coated with a monoclonal antibody specific for clathrin light chain A (Fig. 2 ) and appeared as bright diffraction-limited spots in the clathrin channel. In the case of reconstituted CCVs, the signal from the lipid vesicle stained with membrane-binding dyes was detected at the locations corresponding to immobilized CCVs, whereby different color dyes were used to distinguish vesicles made with different lipid compositions (Fig. 1c) . ATP-loaded Hsc70 labeled with a different fluorophore together with auxilin were then injected into the microfluidic channel to initiate the uncoating reaction (Fig. 2) ; the time course of the fluorescence signals associated with single clathrin coats and Hsc70 are then recorded using multiwavelength time-lapse total internal reflection fluorescence (TIRF) microscopy ( Fig. 2) . Traces of clathrin intensity were extracted from the fluorescence movies at each location corresponding to a single coat, whereby the fluorescence intensity was converted into number of molecules using a calibration value determined by single-molecule photobleaching. The resulting clathrin traces showed the process of clathrin uncoating for individual clathrin structures (Fig. 3) . Likewise, traces of Hsc70 Glass coverslips are coated with a layer of a copolymer composed of poly-L-lysine and biotinylated poly(ethylene glycol) (PLL-PEG) to minimize nonspecific adsorption of proteins to the surface. The surface is then modified with streptavidin followed by the biotinylated monoclonal antibody CVC.6 directed against mutated rat clathrin light chain A. In vitro assembled CCs clathrin coats or CCVs are then captured onto the surface via the antibody (shown here for CCV). Uncoating reagents (Hsc70, auxilin, ATP) are then added to the immobilized clathrin coats or CCV to initiate the uncoating reaction. Different components of the reaction can be labeled with spectrally distinct fluorophores to allow observation of their arrival and/or departure at the locations of individual coats/CCVs by multiwavelength TIRF microscopy Uncoating Start Dwell Times Fig. 3 Kinetics of clathrin-coat disassembly. Single clathrin-coat disassembly tracings after injecting ∆PTEN-Auxilin, Hsc70 with ATP. The stochastic behavior illustrated by differences in the dwell time to start the clathrin lattice disassembly (monitored via labeled clathrin light chain A signal) is shown for five different traces association with the coats were determined from the colocalized signals of Hsc70 at the location of each clathrin coat. The loss of clathrin fluorescence and amount of recruited Hsc70 were determined from several hundred coats imaged in the field of view allowing us to extract kinetic parameters of Hsc70 binding and clathrin uncoating [8] .
Materials
1. Shaker for baculovirus cultures (28C, dark).
2. Sonicator.
3. Metal beaker.
4. Bacterial shaker.
FPLC.
6. Ultracentrifuge Sorvall or equivalent.
7. Benchtop centrifuge for pelleting bacterial/baculovirus cultures.
8. Spectrophotometer.
9. Tissue grinder (e.g., Potter Homogenizer or similar).
10. 0.2 μm syringe filters.
11. Baffled flask for bacterial culture.
12. Spinner flask for baculovirus culture.
13. SDS-PAGE gel electrophoresis setup.
14. Kitchen blender.
15. Argon-flow sample dryer.
16. Electron microscope.
17. Vacuum desiccator.
Laboratory oven (70 °C).
19. Hot plate.
20. Headway spin coater (or similar).
Laurell Spin Coater (or similar).
22. THINKY ARE-250 Mixer.
Technics Plasma etcher 500-II (or similar).
24. Micropuncher to make holes in PDMS.
25. Glow discharge plasma chamber.
26. Access to clean-room facility.
Equipment
Till Böcking et al. 12. 0.5 M DTT.
13. Centrifugal filtration device (MWCO 10 kDa).
14. Glycerol.
1. Construct/bacterial cells: pGEX auxilin 547-910 (N-terminal GST tag, thrombin cleavage site)/E. coli BL21 DE3 [11] .
2. LB medium containing ampicillin (0.1 mg/mL).
1 M isopropyl β-D-1-thiogalactopyranoside (IPTG).
4. Glutathione agarose.
5. Lysis buffer 3: 20 mM HEPES pH 7.6, 100 mM KCl, 0.2 mM EDTA, 20% glycerol, 1% Triton, 0.5 mM DTT, Complete protease inhibitor (Roche Life Science).
6. Wash buffer 1: 25 mM Tris-HCl pH 7, 40 mM NaCl, 0.1 mM EDTA, 0.2 mM TCEP.
7. Elution Buffer 1: 20 mM glutathione in wash buffer; make fresh; adjust pH to 8 with NaOH.
8. 0.5 U/μL thrombin, frozen in 50 μL aliquots.
9. Buffer E (filter before use): 50 mM MES, pH 6.7, 1 mM EDTA, 0.2 mM Tris(2-carboxyethyl)phosphine hydrochloride (TCEP).
10. Buffer F (filter before use): 50 mM MES, pH 6.7, 500 mM NaCl, 1 mM EDTA, 0.2 mM TCEP.
11. Mono S HR 5/5 column, 1 mL bed volume (GE Life Sciences).
1. Construct/bacterial cells: pProEX Hsc70 (N-terminal hexahistidine tag, TEV cleavage site, C-terminal Gly-Cys extension)/E. coli BL21 DE3.
2. LB medium containing 0.1 mg/mL ampicillin.
1 M IPTG.
4. Lysis buffer 4: 50 mM Tris-HCl pH 7.5, 300 mM NaCl, complete protease inhibitor tablet.
5. Cobalt affinity resin (e.g., Talon; (Clontech), or similar). (a) Maleimide-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).
Reagents
(b) 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC).
(c) 18:1 PI(3)P 1,2-dioleoyl-sn-glycero-3-phospho-(1′-myoinositol-3′-phosphate) (ammonium salt).
(d) 18:1 PI(4)P 1,2-dioleoyl-sn-glycero-3-phospho-(1′-myoinositol-4′-phosphate) (ammonium salt).
(e) PI(4,5)P2
L-α-phosphatidylinositol-4,5-bisphosphate (Brain, Porcine) (ammonium salt).
2. Lipid Dyes:
3. YQRL containing peptide (CKVTRRPKASDYQRLNL), lyophilized powder.
4. 20 mM HEPES pH 7.4.
Dimethyl sulfoxide (DMSO).
6. 10 mM β-mercaptoethanol.
7. Chloroform, methanol, and water (4:3:2.25 v/v mixture).
8. Avanti Lipid film extruder set: mini-extruder, two syringes (250 μL), and 50 nm pore size polycarbonate membrane.
1. Coated-vesicle Formation Buffer: (80 mM MES pH 6.5, 20 mM NaCl, 2 mM EDTA, 0.4 mM DTT).
2. Extruded liposomes that are 50-80 nm in diameter (determined by negative stain EM).
3. Recombinant clathrin heavy chain triskelia.
4. Fluorescently labeled recombinant clathrin LCA.
5. AP-2 adaptor complex isolated from bovine brain (see step 3).
6. Dialysis cassette, 10 kDa MWCO. 4. TFOCS (Tridecafluoro-1,1,2,2, tetrahydrooctyl-1-trichloro silane).
5. Methanol.
6. Acetone.
7. Isopropanol.
8. Polydimethylsiloxane (PDMS): 184 sylgard elastomer and curing agent.
1. Glass coverslips (#1.5).
2. Toluene.
3. Dichloromethane.
4. Ethanol.
7. Poly-L-lysine(20 kDa) conjugated with PEG(2 kDa) and PEGBiotin (3.4 kDa) (SuSoS AG, Switzerland).
1. 1 mg/mL streptavidin in PBS.
2. Blocking solution: 20 mM Tris-HCl pH 7.5, 2 mM EDTA, 50 mM NaCl.
3. Biotinylated CVC.6 clathrin light chain A mouse monoclonal antibody.
1. Uncoating Buffer:20 mM imidazole pH 6.8, 100 mM KCl, 2 mM MgCl 2 , 5 mM protocatechuic acid, 50 nM protocatechuate-3,4-dioxygenase, 2 mM Trolox, 8 mM 4-nitrobenzyl alcohol.
2. Uncoating Mix: 1 μM Hsc70, 5 mM ATP, 10 mM MgCl 2 , 25 nM ∆PTEN-auxilin1 in Uncoating Buffer.
3. Inverted fluorescence microscope equipped with the following hardware (Fig. 4) . 
Methodology
1. This procedure uses the Bac-to-Bac system (Invitrogen/ ThermoFisher) to recombinantly express rat clathrin heavy chain based on a pFastBac-based plasmid encoding the heavy chain [10] .
2. Transform DH10Bac cells with the clathrin heavy chain plasmid, and grow the cells on plates containing the appropriate antibiotics (gentamycin, tetracycline, kanamycin), Bluo-Gal, and IPTG. Completing blue-white screening, after 48 h, restreak a white colony. From this second plate, use a single colony to grow a 4 mL culture in LB medium containing the appropriate antibiotics (gentamycin, tetracycline, kanamycin).
Isolate the bacmid DNA sample: lyse the cells with alkaline buffer, add 800 μL isopropanol, incubate on ice for 10 min., centrifuge at 18k × g, and wash the pellet with 70% ethanol.
Expression and Purification of Clathrin Heavy Chain

Expression in Insect Cells
Syringe pump Finally, air-dry the pellet in a fume hood, and resuspend it with Tris-EDTA buffer.
3. Prepare Sf9 cells using Sf900-II medium. Transfect cells in 6-well plates with the clathrin heavy chain bacmid according to the manufacturer's protocol.
4. After 3-5 days, isolate the cell supernatant to obtain a baculovirus stock.
5. Amplify the virus stock by infecting Sf9 cells and isolating the cell supernatant after considerable cell death is observed by Trypan Blue staining. Complete a second round of amplification.
6. Express clathrin heavy chain by using High Five cells grown in spinner flasks and Express Five or Excell 420 medium.
7. Prepare the cells to a density of 1.2-1.5 × 10 6 cells/mL (typically 2 × 500 mL), and infect them with the baculovirus stock (typically using an amount of the stock equal to 1% of the culture volume see Note 5).
8. Incubate in spinner flask for 2.5-3 days @ 28 °C.
9. Spin cells at 1500 rpm for 10 min in conical plastic bottles.
Add one Complete tablet to 25 mL ice-cold Lysis Buffer 1.
Resuspend the cells by quickly vortexing with 10 mL of the buffer, and then add remainder of the buffer.
11. Sonicate the material on ice for five periods of 60″ (with pauses of 120″) in a metal beaker.
12. Ultracentrifuge the lysate at 4 °C (e.g., TLX 100.4 rotor for 20 min at 438,813.5 × g).
13
. Dialyze the supernatant in Cage Formation Buffer o/n at 4 °C; exchange once.
14. Spin the sample for 10 min at 1000 rpm in a table-top centrifuge; withdraw most of the supernatant (except for 2-3 mL), vortex, and spin again at 3000 rpm to recover more supernatant.
15. Ultracentrifuge the supernatant at 4 °C (e.g., Type 60 Ti for 1 h at 203,347.1 × g).
16
. Supplement Buffer A with 2 mM PMSF or 0.6 mg/mL PEFA, and 3 mM EDTA. Using this solution, resuspend the pellet from step 9 initially by pipetting, and then using a tissue grinder (Potter homogenizer; 5 strokes).
17. Add Buffer B (half the volume of that for Buffer A used in step 10), mix, and shake gently at room temperature for 15 min on a rocker.
Cell Lysis and Purification of Clathrin Heavy Chain
18. Ultracentrifuge the sample in a TLA 100.4 for 20 min at 541,700 × g and 4 °C.
19. Filter the supernatant (0.2 μ syringe filter), and load onto a gel filtration (Sephacryl S-500) column equilibrated with Column Buffer.
1. Use an FPLC at room temperature.
2. Wash the column with high phosphate buffer, and equilibrate it with low phosphate buffer.
3. Inject the sample onto the column, and wash by using five column volumes of low phosphate buffer.
4. Add 15 μL100 mM EGTA solution to the receiving tubes.
5. Elute the sample using a gradient of 0-100% high phosphate buffer.
6. Pool fractions that contain clathrin according to SDS-PAGE, and add glycerol to 20%. Aliquot the sample into 500 μL portions, and freeze by submerging the aliquots in liquid nitrogen for storage at −80 °C. Approximate expected concentration is 1 mg/mL.
1. Inoculate 100 mL LB medium containing kanamycin (30 μg/ mL) with a colony of BL21(DE3) bacteria transformed with a pET28-based vector for expression of rat light chain a1 (LCA) with mutations D203E and C218S (see Note 6). Grow an overnight culture at 37 °C with shaking at 250 rpm.
2. Inoculate 1 L LB medium containing kanamycin (30 μg/mL) in baffled flasks with 10 mL of saturated culture. Grow at 37 °C with shaking at 250 rpm until the OD(600) reaches approximately 0.5 (2.5-3 h).
3. Induce expression by addition of 0.6 mL 1 M IPTG (final concentration of 0.6 mM), and continue growth at 37 °C and 250 rpm for 3 h.
4. Pellet cells by centrifugation (5000 rpm, 4500 × g, 10 min, 4 °C).
5. Resuspend the bacterial cell pellet in cold Lysis Buffer 2 (volume ~20 mL).
6. Place suspension into conical flask and immerse in boiling water for 6 min, then chill on ice. The solution becomes turbid. Add fresh DTT solution to a concentration of 0.5 mM.
7. Centrifuge to pellet denatured protein and cell debris using a 60Ti rotor, 292,819.8 × g, 30 min, 4 °C. The supernatant contains the light chain.
8. Dialyze the supernatant against 1 L Lysis Buffer 2 (without protease inhibitors) at 4 °C overnight. 18. Dilute the solution tenfold with Buffer C (without DTT) and remove the excess dye by centrifugal ultrafiltration. Repeat this process until the flow-through is colorless.
19. The labeled protein can be further purified with the chromatography conditions as described above in step 11 using buffers without DTT and a linear gradient from 0-65% Buffer D over 40 column volumes.
20. Measure the UV-visible absorption spectrum of the sample. Determine the protein concentration and degree of labeling by using the extinction coefficient of the protein at 280 nm calculated from its sequence, the extinction coefficient of the fluorophore as provided by the manufacturer, and the correction factor for absorption of the fluorophore at 280 nm. Add glycerol up to 20% final concentration to the protein solution, divide into aliquots, and freeze in liquid nitrogen for storage at −80 °C.
1. Inoculate 100 mL LB medium containing ampicillin (0.1 mg/ mL) with a colony of BL21(DE3) bacteria transformed with a pGEX vector for expression of auxilin 547-910. Grow an overnight culture at 37 °C with shaking at 250 rpm.
2. Inoculate 1 L LB medium containing ampicillin (1 mg/mL) in baffled flasks with 10 mL o/n culture and grow at 37 °C with (GST expected in the flow through; auxilin appears early in the gradient).
22. SDS PAGE to identify fractions containing auxilin, combine fractions, concentrate if needed (centrifugal filter, 10 kD MWCO).
23. Add 20% glycerol to the protein solution, divide into aliquots and freeze in liquid nitrogen for storage at −80 °C. Approximate protein yield should be 0.1-0.5 mg/mL.
1. Inoculate 100 mL LB medium containing ampicillin (0.1 mg/ mL) with a colony of BL21(DE3) bacteria transformed with a vector for expression of Hsc70 containing a Gly-Cys extension at the C-terminus and an N-terminal, TEV cleavable hexahistidine-tag. Grow an overnight culture at 37 °C with shaking at 250 rpm.
2. Inoculate 1 L LB medium containing ampicillin (0.1 mg/mL) in baffled flasks with 10 mL o/n culture and grow at 37 °C with shaking at 250 rpm until the OD(600) reaches approximately 0.3. 12. Elute with Elution Buffer 2. Collect 0.5 mL fractions in tubes containing EDTA solution (final concentration of 2 mM).
13. SDS PAGE to identify fractions containing Hsc70. 
Expression, Purification and Labeling of Hsc70
Dialyze against Lysis Buffer 4 (without protease inhibitor).
17. Incubate protein with Cobalt affinity resin (1 mL settled bed volume, equilibrated with Lysis Buffer 4) by head-over-head rotation at 4 °C for 2 h. TEV protease and Hsc70 with uncleaved hexahistidine tag binds to the beads during this step.
18. Pour beads into column, let drain and collect the flow-through (containing Hsc70 without hexahistidine tag).
19. Add 0.1 mM TCEP, 1 mM MgCl 2 , and 0.1 mM ATP (final concentrations) and concentrate using a centrifugal filtration device (30 kDa MWCO). Centrifuge to remove aggregates (benchtop centrifuge, 20,000 × g, 4 °C, 10 min). Expected concentration ~2 mg/mL. Samples can be stored at −80 °C.
20. Add a thiol-reactive fluorophore (e.g., Alexa Fluor-C5-maleimide) in a ratio of 5:1 (fluorophore-protein, mol/mol) to the Hsc70 solution and incubate for 80 min at room temperature.
Quench unreacted fluorophore with 2-mercaptoethanol (final concentration of ~10 mM).
22. Separate the labeled Hsc70 from the free fluorophore by gel filtration on a Superose 6 HR 10/30 column operated at 0.5 mL/min with column buffer.
23. Identify and combine fractions containing labeled Hsc70 and concentrate by centrifugal ultrafiltration as described above in step 19.
24. Determine the protein concentration and degree of labeling using UV-visible absorption spectroscopy and the formula provided by the manufacturer. Add 20% glycerol to the protein solution, divide into aliquots and freeze in liquid nitrogen for storage at −80 °C.
1. On the day prior to preparation: Store Buffer G, centrifuge bottles, and blender at 4 °C. Prepare Buffer B and store at room temperature. On the morning of preparation: Precool centrifuges to 4 °C. Prepare Ficoll/sucrose solution. Prepare Column Buffer 3 and store at room temperature.
2. Process brains immediately upon delivery. Cut the brains in halves, and wash them in a 4 L beaker containing cold tap water and ice.
3. Add 400 mL of Buffer G to the blender. 4. Keeping brains in ice-cold water, remove white matter and large vessels, cut remainder into cubes (~2.5 cm in each dimension), and place in blender. It is not essential to get rid of all white matter; just cut off the brainstem.
5. Add 10 mL of 50 mM PMSF solution, blend on a low setting for 1 min, then on a high setting for another 2 min. The sample should look homogeneous with a pinkish color.
6. Spin in a JA-10 rotor (Beckman J2-HS centrifuge) for 30 min at 17,650 × g and 4 °C.
7. Carefully pour off supernatants.
8. Add 60 mL of Buffer G to remaining pellets and shake vigorously to resuspend; pour suspended pellets into blender and blend on a low setting for 1 min.
9. Spin the resuspended pellets in JA-14 rotor in Beckman J2-HS centrifuge for 45 min at 30,000 × g and 4 °C.
Load the supernatants into Type 45
Ti tubes (70 mL).
Spin in Type 45
Ti rotor (Beckman) for 60 min at 224,500 × g and 4 °C.
12. Following each spin, pour off and discard the supernatant. Resuspend 5 to 6 pellets by adding 10 mL Buffer G to only one tube, and then swirl to dislodge pellet. Pour this into next tube and remove that pellet. Repeat until all pellets are in solution. Add Buffer G until the total volume is 20 mL. Add PMSF from 50 mM stock (1:100, 200 μL).
13. Homogenize pellets with 5-10 strokes using a motor driven Potter homogenizer; make sure that no particulate is left.
14. Collect homogenate in a 50 mL conical tube. 29. Carefully remove and save the supernatant except for ~2 mL on top of the fluffy pellet. Collect this remaining volume, spin it again in the TLA-100.4 rotor (TLX centrifuge; Beckman) for 20 min at 541,700 × g and room temperature, and add it to the rest. Pass the solution through a syringe filter (0.2 μm) and store it in a 50 mL conical tube.
30. Load the sample onto a Sepharose CL-4B column and run at 1 mL/min. Collect fractions of 5 mL. Clathrin appears as a broad peak after the void, followed by a small peak containing AP-1 and AP-2.
31. Pool clathrin fractions, add EGTA to a final concentration of 1 mM and store at 4 °C. Pool AP fractions and store at 4 °C overnight.
32. Connect the hydroxyapatite column to the FPLC system at 4 °C. Put a 0.2 μm syringe filter at the inlet of the column. Operate at 1 mL/min for all steps. Wash the column with 20 mL of high phosphate buffer, and equilibrate it with low phosphate buffer.
33. During the equilibration phase, load the 50 mL Superloop with the AP sample.
34. Inject the APs, and continue running low phosphate buffer.
35. Elute AP-1 and AP-2 from the column using the following gradient program: 0-60% high phosphate buffer over 24 mL, and then a step to 100% high phosphate buffer, with continued elution for 20 mL (see Note 9). 6. Immediately withdraw supernatant with a 1 mL pipette. The pellet should have a hemispherical dome shape and be colorless and translucent.
7. Wash carefully with Coat Formation Buffer around the pellet.
Add Clathrin Coat Formation Buffer or Coated-Vesicle
Formation Buffer to the tube (use a volume of 120 μL for a pellet with a diameter of ~3 mm), allow to stand at room temperature for 10-15 min in the dark, then slowly wash buffer over the pellet using a micropipettor to resuspend, avoiding foaming.
9. Coats can be stored frozen at −80 °C in the presence of 20% glycerol (snap-freeze in liquid nitrogen).
10. Prepare a mix of 20 mg/mL of YQRL containing peptide (CKVTRRPKASDYQRLNL; prepared in 20 mM HEPES buffer pH 7.4), DMSO, and maleimide-DOPE (1:1:2 v/v mixture respectively).
11. Vortex the mixture at 1000 rpm for 2 h at room temperature.
12. Add 10 mM β-mercaptoethanol to the coupling reaction in order to quench any unreacted groups.
13. Extract the YQRL peptidolipid by adding chloroform, methanol, and water (4:3:2.25 v/v mixture) and centrifuging at 1000 rpm for 5 min. 6. Replace the dialysis buffer and redialyze for an additional 4 h at 4 °C.
In Vitro
7. Transfer the dialyzed CCV mixture into an 1.5 mL tube and spin down at max speed on a benchtop centrifuge at 4 °C for 10 min in order to remove large aggregates.
8. Transfer the supernatant into a fresh tube and centrifuged in a TLA-100.4 at 265,500 × g for 30 min at 4 °C.
9. Withdraw and discard the supernatant.
10. Using a micropipettor resuspend the CCV containing pellet in Coated-vesicle Formation Buffer (in 100 μL of buffer per 100 μg of clathrin heavy chain; avoid foaming) and centrifuge a second time at 265,500 × g for 30 min at 4 °C.
11. Withdraw and discard the supernatant.
12. Resuspend the final pellet in Coated-vesicle Formation Buffer and use the CCVs immediately for best results.
1. To prevent channels from collapsing or sagging, the height (h ) and width (w) of channels, and space (s) between channels should correspond to the following optimized values: h = 50 μm (variable and controlled below using the spin speed and viscosity of the photoresist); w = 200 μm; s = 500 μm.
2. Design the mask (using CAD program of your choice) while optimizing the number of channels per chip, and number of chips per silicon wafer (default: 5-7 channels per chip, 10-13 chips per wafer, typical channel length 10 mm).
3. Pour negative photoresist on silicon wafer, and spin-coat for 50 μm (or desired) thickness.
4. Place mask over the silicon wafer with prebaked (on a hot plate) photoresist and expose to UV (duration based on thickness of the photoresist).
5. Develop (to remove non-UV exposed photoresist) wafer to create a master wafer, using developing times specified by the manufacturer.
6. Place wafer in vacuum desiccator with a petri dish containing TFOCS (tridecafluoro-1,1,2,2, tetrahydrooctyl-1-trichlorosilane) for 30 min to deposit a monolayer.
7. This step is critical to make sure that PDMS does not stick to the master wafer.
8. Repeat the passivation process after casting >20-30 PDMS molds.
9. Pour and mix PDMS and curing agent in 10:1 ratio and degas to remove bubbles. 11. Carefully peel the cured PDMS mold from the master wafer, and cover with adhesive Scotch tape.
12. Using micropuncher, punch holes at the channel edges to create an inlet and outlet (see Note 11).
13. Cut and shape the PDMS device with inlet and outlet punched holes to fit the imaging coverslip.
14. Plasma treat (by glow discharging) precleaned coverslip and PDMS for 20-40 s at 0.35 mBar pO 2 (using purged oxygen plasma; air plasma may also be used, however, bonding conditions should be optimized since the quality of adhesion varies based on atmospheric compositions, humidity levels, power, etc.; see Note 12) [12] .
15. Immediately join the two plasma exposed surfaces, press gently to remove any air bubbles and heat for 5 min at 100 °C on a hot plate to improve bonding strength.
16. Functionalize devices immediately using PLL-PEG solution, or store devices in clean room until ready for use. 2. Add ~200 μL of MilliQ water containing fluorescent beads, and place on the microscope in order to calibrate the TIRF angle.
3. Set the TIRF slider angle such that the laser illumination is passing straight through the objective (warning: laser illumination will no longer be confined within the microscope).
4. Set the laser power and exposure such that the emission counts from the immobilized beads are ~2-5% of the EMCCD's max dynamic range.
5. At this point, you will observe a mix of immobilized beads and free-floating beads.
6. Optimize the evanescent filed: Adjust the TIRF slider angle to maximize the signal from the immobilized beads and minimize signal from the floating beads. Ideally, set the angle between 70 and 80% of maximum TIRF, as this will reduce the background fluorescence from injected solutions.
Single-Molecule Calibration
7. Prepare a coverslip with immobilized fluorophores in the femtomolar to picomolar-range required to resolve single fluorophores (labeled clathrin LCA adsorbs to glass coverslips cleaned as in Subheading 3.10, step 1 followed by glow discharge; oxygen plasma is not required; however, conditions should be optimized since the extent of adsorption varies depending on atmospheric compositions, humidity levels, etc.).
8. Adjust the power and exposure such that you are able to detect the signal from single fluorophores with a signal-to-noise ratio of 5 or higher. Fix the power and image and subsequently bleach the fluorophores; repeat this process at different exposures and extract the single bleaching step-sizes in order to generate a single molecule fluorescence signal calibration curve.
9. Adjust the laser power such that imaging is carried out with one fluorophore sensitivity with exposures of 150-200 ms. 6. The cDNA of rat clathrin light chain a1 was cloned into the pET28 expression vector using the NcoI and EcoRI restriction sites to allow expression without tags. The point mutations were introduced using site-directed mutagenesis. The mutation D203E restores the epitope recognized by the monoclonal antibody CVC.6 (which is used to capture clathrin coats onto the glass coverslip surface for imaging). The mutation C218S removes one of the two cysteines in the light-chain sequence to allow site-specific labeling at C187 with thiolreactive reagents.
7. The dye can be stored in aliquots at −20 °C for an extended period of time (>1 year). Prepare a 10 mM stock solution of the dye in water, divide into aliquots (e.g., 10 μL in 0.2 mL microcentrifuge tubes) and evaporate to dryness for storage in an airtight container containing a desiccant. The dye aliquots can be redissolved in water or buffer and added to the desired concentration to the protein solution for labeling.
Biochemistry 23, 4420-4426 (1984).
9. The elution profiles for AP-1 and AP-2 tend to vary considerably from one purification to the other; AP-1 is eluted first and tends to be eluted from the column in three to four 1 mL fractions. The step to 100% buffer B in the gradient is meant to coincide with the elution of AP-2 and was included to elute AP-2 at high concentration from the column. The fractions containing the APs need to be verified by SDS-PAGE.
10. The volume of the solution for coat formation is typically 0.5 mL. The concentration of clathrin heavy chain should be around 1 mg/mL.
11. Use only nitrile gloves, not latex, when handling PDMS to preserve adhesive functionality.
12. Over exposure to plasma may damage surfaces and affect bonding strength.
13. Caution: Please make sure that appropriate laser safety precautions are observed during the microscope calibration and imaging experiments.
